Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Jun-Shuai Xue"'
Autor:
Jun-Shuai Xue, Hui Liu, Rui-Zhe Li, Si-Yu Tan, Yu-Chuan Yan, Zhao-Ru Dong, Jian-Guo Hong, En-Yu Liu, Qiang-Bo Zhang, Zhi-Qiang Chen, Dong-Xu Wang, Tao Li
Publikováno v:
Clinical Surgical Oncology, Vol 2, Iss 4, Pp 100025- (2023)
Background: Combination immunotherapy has gradually become the mainstay of systematic therapy for advanced hepatocellular carcinoma (HCC), however, whether preoperative immunotherapy has the potential to reduce tumor activity, increase the resection
Externí odkaz:
https://doaj.org/article/50083296ce98428691a90684c5949b31
Autor:
Yun-Long Ma, Ya-Fei Yang, Han-Chao Wang, Chun-Cheng Yang, Lun-Jie Yan, Zi-Niu Ding, Bao-Wen Tian, Hui Liu, Jun-Shuai Xue, Cheng-Long Han, Si-Yu Tan, Jian-Guo Hong, Yu-Chuan Yan, Xin-Cheng Mao, Dong-Xu Wang, Tao Li
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Intracellular copper homeostasis requires a complex system. It has shown considerable prospects for intervening in the tumor microenvironment (TME) by regulating copper homeostasis and provoking cuproptosis. Their relationship with hepato
Externí odkaz:
https://doaj.org/article/5178977acb0f472eb2cff726a6e9c46e
Autor:
Jun-Shuai Xue, Zi-Niu Ding, Guang-Xiao Meng, Lun-Jie Yan, Hui Liu, Hai-Chao Li, Sheng-Yu Yao, Bao-Wen Tian, Zhao-Ru Dong, Zhi-Qiang Chen, Jian-Guo Hong, Dong-Xu Wang, Tao Li
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundNatural killer (NK) cells play major roles in eliminating tumor cells. Preliminary studies have shown that NK cells and their receptors/ligands have prognostic value in malignant tumors. However, the relevance of NK cells and their receptor
Externí odkaz:
https://doaj.org/article/358fdd875236470b85f6a61a1770c82c
Autor:
Cheng-Long Han, Guang-Xiao Meng, Zi-Niu Ding, Zhao-Ru Dong, Zhi-Qiang Chen, Jian-Guo Hong, Lun-Jie Yan, Hui Liu, Bao-Wen Tian, Long-Shan Yang, Jun-Shuai Xue, Tao Li
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundThe relationship between baseline C-reactive protein (CRP) level and the prognosis of cancer patients receiving immune checkpoint inhibitor (ICI) treatment remains controversial. The aim of this meta-analysis was to clarify whether baseline
Externí odkaz:
https://doaj.org/article/db554a9925e241468150452c19431094
Autor:
Hui Liu, Chun-Cheng Yang, Yun-Long Ma, Ya-Fei Yang, Lun-Jie Yan, Zi-Niu Ding, Jun-Shuai Xue, Long-Shan Yang, Yu-Chuan Yan, Zhao-Ru Dong, Dong-Xu Wang, Zhi-Qiang Chen, Jian-Guo Hong, Tao Li
Publikováno v:
Immunotherapy. 15:669-678
Aims: This work was designed to identify the subgroup of advanced hepatocellular carcinoma (HCC) patients for whom treatments containing immune checkpoint blockers (ICBs) were most effective. Materials & methods: A meta-analysis was performed to expl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f89dc3d7cb1105ca72fc0239483fd14b
https://doi.org/10.2217/imt-2022-0114
https://doi.org/10.2217/imt-2022-0114
Autor:
Bao-Wen Tian, Lun-Jie Yan, Zi-Niu Ding, Hui Liu, Guang-Xiao Meng, Jun-Shuai Xue, Cheng-Long Han, Zhao-Ru Dong, Jian-Guo Hong, Zhi-Qiang Chen, Dong-Xu Wang, Tao Li
Publikováno v:
Expert Review of Gastroenterology & Hepatology. 17:73-83
The prognostic value of alpha-fetoprotein (AFP) response for efficacy of targeted therapy or immune checkpoint inhibitors (ICIs) has not been established. The purpose of this meta-analysis is to elucidate the relationship between AFP response and sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f157084a27b97239e0619def3d61028
https://doi.org/10.1080/17474124.2022.2156859
https://doi.org/10.1080/17474124.2022.2156859
Autor:
Bao-Wen Tian, Ya-Fei Yang, Chun-Cheng Yang, Lun-Jie Yan, Zi-Niu Ding, Hui Liu, Jun-Shuai Xue, Zhao-Ru Dong, Zhi-Qiang Chen, Jian-Guo Hong, Dong-Xu Wang, Cheng-Long Han, Xin-Cheng Mao, Tao Li
Publikováno v:
Immunotherapy. 14:1481-1496
Objective: This meta-analysis was designed to explore the association between the systemic immune–inflammation index (SII) and the therapeutic effect of immune checkpoint inhibitors. Materials & methods: The authors retrieved relevant studies publi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d552e2f42ff547d9b820c1bbbf7966b
https://doi.org/10.2217/imt-2022-0133
https://doi.org/10.2217/imt-2022-0133
Autor:
Zi-Niu Ding, Guang-Xiao Meng, Jun-Shuai Xue, Lun-Jie Yan, Hui Liu, Yu-Chuan Yan, Zhi-Qiang Chen, Jian-Guo Hong, Dong-Xu Wang, Zhao-Ru Dong, Tao Li
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 149:1993-2008
Immune checkpoint inhibitors (ICIs) have been explored as first-line treatment in various types of previously untreatable malignancies, while limited evidence is available on the management of hepatitis B virus (HBV) in patients undergoing immunother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a91f3e93837318f2f7bb4479360373e7
https://doi.org/10.1007/s00432-022-04133-8
https://doi.org/10.1007/s00432-022-04133-8
Autor:
Cheng-Long Han, Bao-Wen Tian, Lun-Jie Yan, Zi-Niu Ding, Hui Liu, Xin-Cheng Mao, Jin-Cheng Tian, Jun-Shuai Xue, Si-Yu Tan, Zhao-Ru Dong, Yu-Chuan Yan, Jian-Guo Hong, Zhi-Qiang Chen, Dong-Xu Wang, Tao Li
Publikováno v:
Cancer Immunology, Immunotherapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5398bf76890a749cf94ab0984f101121
https://doi.org/10.1007/s00262-023-03390-x
https://doi.org/10.1007/s00262-023-03390-x
Autor:
Jun-Shuai Xue, Hui Liu, Rui-Zhe Li, Si-Yu Tan, Yu-Chuan Yan, Zhao-Ru Dong, Jian-Guo Hong, En-Yu Liu, Qiang-Bo Zhang, Zhi-Qiang Chen, Dong-Xu Wang, Tao Li
Background: Combination immunotherapy have gradually become the mainstay of systematic therapy for hepatocellular carcinoma (HCC), however, prescribing immunotherapies perioperatively has the potential to reduce tumor activity, while increasing the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::315039d5b42ef33710dfcd5c271397af
https://doi.org/10.21203/rs.3.rs-2546520/v1
https://doi.org/10.21203/rs.3.rs-2546520/v1
